A Simple Analysis of 4-Methylimidazole Using Automated Solid-Phase Extraction and High Performance Liquid Chromatography with MS-MS and MS–SIM Detection
Special Issues
This work will demonstrate a simple methodology using automated solid-phase extraction (SPE) and HPLC coupled with mass spectrometric detection. This work will demonstrate a simple methodology using automated solid-phase extraction (SPE) and HPLC coupled with mass spectrometric detection. This work will demonstrate a simple methodology using automated solid-phase extraction (SPE) and HPLC coupled with mass spectrometric detection.
The compound 4-methylimidazole (4-MEI) is formed as a by-product in some foods and beverages. Caramel coloring Type III and Type IV in beverages is one of the ingredients which may contain 4-MEI and it may be found in products such as certain colas, beers, soy sauces, breads, coffee, ammoniated livestock feed, and others. There has been an increase in concern lately about 4-MEI being a suspected carcinogen. Europe has regulated the amount of 4-MEI allowed in coloring used in food products. The state of California has added 4-MEI to its proposition 65 list of known carcinogens. California now requires products with an exposure potential of >29 µg/day to carry warning labels.
This work will demonstrate a simple methodology using automated solid-phase extraction (SPE) and HPLC coupled with mass spectrometric detection.
The SmartPrep® Cartridge Extractor was used with a Waters Oasis® MCX 3 cc (60 mg) cartridge. The extraction method was optimized using a series of conditions and collecting fractions on the SmartPrep (1).
The samples for this experiment were common soft drinks containing caramel coloring. The point of purchase and original product production site are variables in 4-MEI levels. Some of the beverages were purchased in New England and others in California, in common supermarkets and their bottling origin is listed with the results.
Results and Discussion
Figure 1: Mexican soda sample, S/N = 383 for quantitation ion.
A sensitive method for 4-MEI detection was developed using HPLC–MS, showing adequate measurement below the California Prop 65 requirements of 29 µg per day. Solid-phase extraction was shown to adequately concentrate the 4-MEI from the soft drinks analyzed and provide clean-up. Two samples were shown to exceed the daily exposure limits in Prop 65 with one serving.
Reference
- “A Simple Analysis of 4-Methylimidazole Using Automated Solid Phase Extraction and High Performance Liquid Chromatography with MS-MS and MS-SIM Detection,” AN1111606_01, available from www.horizontechinc.com.
Horizon Technology, Inc.
16 Northwestern Drive, Salem, NH 03079
tel. (603) 893-3663
Website: www.horizontechinc.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
